Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 583 of 1,261
  1. US 9884841

    Small molecule inhibitors of Mcl-1 and uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  2. US 9885014

    Re-conditioned serum-free culture medium composition obtained by culturing mammalian cells in Fibromodulin

    The Regents of the University of California · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  3. US 9884072

    Methods and compositions for modulating apolipoprotein (a) expression

    Ionis Pharmaceuticals, Inc. · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  4. US 9885045

    Methods and compositions for modulating apolipoprotein (a) expression

    Ionis Pharmaceuticals, Inc. · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  5. US 9885047

    Modulation of TMPRSS6 expression

    Ionis Pharmaceuticals, Inc. · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  6. US 9885051

    Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  7. US 9885042

    miR-92 inhibitors and uses thereof

    MIRAGEN THERAPEUTICS, INC. · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  8. US 9885026

    Modified cascade ribonucleoproteins and uses thereof

    Caribou Biosciences, Inc. · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  9. US 9885018

    High efficiency reprogramming of fibroblasts into cardiomyocytes

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  10. US 9884908

    Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  11. US 9884907

    Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  12. US 9884868

    TGF-beta inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  13. US 9884863

    STAT3 inhibitor

    The Board of Regents of the University of Texas System · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  14. US 9884875

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  15. US 9884866

    Immunomodulators and immunomodulator conjugates

    Regents of the University of Minnesota · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  16. US 9884859

    Solid form of pyrazolopyridine compound

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  17. US 9884820

    Pro-neurogenic compounds

    The Board of Regents of the University of Texas System · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  18. US 9884100

    Lutzomyia longipalpis polypeptides and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  19. US 9884114

    Methods of rational nicotine hapten design and uses thereof

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  20. US 9884104

    Live attenuated virus vaccines for la crosse virus and other bunyaviridae

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  21. US 9884097

    Fungal immunogens and related materials and methods

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  22. US 9884076

    Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy

    Capricor, Inc. · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  23. US 9884096

    Compositions and methods related to graft versus host disease and treatments thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  24. US 9884050

    Inhibition of crystal growth of roflumilast

    Arcutis, Inc. · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.